The 10 analysts offering 12-month price forecasts for Mesoblast Ltd have a median target of 17.63, with a high estimate of 27.26 and a low estimate of 6.14. The median estimate represents a +9.47% increase from the last price of 16.10.
The current consensus among 10 polled investment analysts is to Buy stock in Mesoblast Ltd. This rating has held steady since December, when it was unchanged from a Buy rating.Move your mouse over past months for detail
Earnings and Sales Forecasts
Earnings per Share -$0.10
Reporting Date Feb 17
Earnings per Share
Move your mouse over a quarter or year to see how estimates have changed over time.